Flputnam Investment Management CO Pfizer Inc Transaction History

Flputnam Investment Management CO

$5.82 Billion
Q3 2024

A detailed history of Flputnam Investment Management CO transactions in Pfizer Inc stock. As of the latest transaction made, Flputnam Investment Management CO holds 234,603 shares of PFE stock, worth $6.27 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

234,603

Previous 248,446 5.57%

Holding current value

$6.27 Million

Previous $6.95 Million 2.33%

% of portfolio

0.12%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $383,451 - $434,531	-13,843 Reduced 5.57%	234,603 $6.79 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $2,702 - $3,167	-107 Reduced 0.04%	248,446 $6.95 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $856,829 - $983,914	-33,095 Reduced 11.75%	248,553 $6.9 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $263,625 - $342,420	-10,089 Reduced 3.46%	281,648 $8.11 Million
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $273,599 - $319,810	-8,526 Reduced 2.84%	291,737 $9.68 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.75 Million - $3.18 Million	76,051 Added 33.92%	300,263 $11 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $3.36 Million - $4.38 Million	85,334 Added 61.45%	224,212 $9.15 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $315,129 - $411,366	-7,548 Reduced 5.15%	138,878 $7.12 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $375,854 - $458,824	8,589 Added 6.23%	146,426 $6.41 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $16,518 - $19,585	-355 Reduced 0.26%	137,837 $7.23 Million
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $60,893 - $75,454	-1,331 Reduced 0.95%	138,192 $7.15 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $102,845 - $152,451	2,489 Added 1.82%	139,523 $8.24 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $174,427 - $224,066	-4,444 Reduced 3.14%	137,034 $5.89 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $204,543 - $231,713	-5,696 Reduced 3.87%	141,478 $5.54 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $168,555 - $190,096	-5,033 Reduced 3.31%	147,174 $5.33 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $189,373 - $240,804	-5,658 Reduced 3.58%	152,207 $5.6 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $77,470 - $90,890	2,440 Added 1.57%	157,865 $5.79 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $39,517 - $47,940	1,312 Added 0.85%	155,425 $5.08 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $353,146 - $504,570	-13,065 Reduced 7.82%	154,113 $5.03 Million
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $725,523 - $823,377	-22,039 Reduced 11.65%	167,178 $6.55 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $651,976 - $845,422	20,067 Added 11.86%	189,217 $6.8 Million
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $68,228 - $76,604	-1,845 Reduced 1.08%	169,150 $7.33 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $325,125 - $357,204	8,670 Added 5.34%	170,995 $7.26 Million
Q4 2018 Feb 22, 2019	BUY	$38.47 - $43.86 $1.25 Million - $1.43 Million	32,529 Added 25.06%	162,325 $7.09 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $26,197 - $31,775	760 Added 0.59%	129,796 $5.72 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $14,049 - $14,978	426 Added 0.33%	129,036 $4.68 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $49,492 - $57,418	1,551 Added 1.22%	128,610 $4.56 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $115,412 - $122,456	-3,470 Reduced 2.66%	127,059 $4.6 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $4.05 Million - $4.46 Million	130,529	130,529 $4.66 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Account

Flputnam Investment Management CO Pfizer Inc Transaction History